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Body mass index (BMI) has been inversely associated with lung and upper aerodigestive tract (UADT) cancers. However, only a
few studies have assessed BMI change in adulthood in relation to cancer. To understand the relationship between BMI change
and these cancers in both men and women, we analyzed data from a population-based case–control study conducted in Los
Angeles County. Adulthood BMI change was measured as the proportional change in BMI between age 21 and 1 year before
interview or diagnosis. Five categories of BMI change were included, and individuals with no more than a 5% loss or gain were
defined as having a stable BMI (reference group). Adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were
estimated using logistic regression models. Potential confounders included age, gender, ethnicity, education, tobacco smoking
and energy intake. For UADT cancers, we also adjusted for alcohol drinking status and frequency. A BMI gain of 25% or higher
in adulthood was inversely associated with lung cancer (OR 0.53, 95% CI 0.33–0.84) and UADT cancers (OR 0.44, 95% CI 0.27–
0.71). In subgroup analyses, a BMI gain of 25% was inversely associated with lung and UADT cancers among current and
former smokers, as well as among current and former alcohol drinkers. The inverse association persisted among moderate and
heavy smokers (20 pack-years). The observed inverse associations between adulthood BMI gain and lung and UADT cancers
indicate a potential role for body weight-related biological pathways in the development of lung and UADT cancers.
Body mass index (BMI) is a proxy measure for body fat and is
based on body weight and height. BMI has been positively asso-
ciated with cancers of the colon, kidneys, liver, pancreas, breast
and uterus, as well as with melanomas and adenocarcinoma of
the esophagus.1–9 However, BMI has been inversely associated
with lung cancer and squamous cell carcinoma of the upper
aerodigestive tract (SCC UADT),9–16 which suggests that low
BMI (leanness) may increase the risk of these cancers.17–19
The use of BMI at a single time point during the lifespan, in
relation to cancer development, might not be sufficient for
examining the possible effect of obesity, as BMI might change
over time. An informative approach would involve BMI change
(either gain or loss) between at least two separate times during
the lifespan. Only a few studies have examined the association
between BMI change and lung or UADT cancers. For lung can-
cer, an inverse association was observed with BMI gain in two
cohort studies.20,21 For UADT cancers, an inverse association
with BMI gain was reported in two case–control studies in
Europe.11,19 In the United States, there has been no published
study in both men and women investigating the role of BMI
change in the development of both lung and UADT cancers
and of possible effect modification by tobacco smoking. There-
fore, we conducted our analyses on the association between
BMI change and lung and UADT cancers in a population-based
case–control study in Los Angeles County, California, USA.
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Epidemiologic data were collected in a population-based
case–control study of lung and UADT cancers, in both men
and women, conducted in Los Angeles County, California,
USA. The detailed study design and population have been
described elsewhere.22,23 Eligible cases and controls were resi-
dents of Los Angeles County between the ages of 18–65
years. They were recruited and interviewed between 1999 and
2004. Participants who either spoke English or Spanish or
had translators available at home were interviewed. Lung
cancer cases (n ¼ 611) and UADT cancer cases (n ¼ 601)
were newly diagnosed and identified by the Los Angeles
County Cancer Surveillance Program.22 UADT cancer cases
included oral/pharyngeal, laryngeal and esophageal (adeno-
carcinoma and squamous cell) cancers. Cases were confirmed
pathologically (>95%) or by magnetic resonance imaging or
computed axial tomography. Controls with no history of
investigated cancers were recruited from the neighborhood of
the cases. Cases and controls (1:1) were individually matched
by age (within 10-year categories) and gender. Controls were
residents of Los Angeles County at the time of diagnosis for
cases or at study entry for controls, 18–65 years of age during
the enrollment period, and spoke English or Spanish or had
translators available at home. As we could not identify suffi-
cient eligible controls for all cases during the study period
and to increase power of the study, we decided to analyze
the data by breaking the individual matching and using all
controls for both lung and UADT cancers as a common con-
trol group in an unconditional logistic regression model.
Among contacted and eligible participants, recruitment
rates were 79% for controls, 39% for lung cancer cases and
46% for UADT cancer cases. Informed consent and research
protocols were approved by the Institutional Review Boards
of the University of California, Los Angeles and University of
Southern California. Written informed consent was obtained
from individual study participants. A standardized question-
naire was administered to all participants by trained inter-
viewers with individual interview sessions of 40–60 min.
The standardized questionnaire was used to collect data on
participant demographics, occupational history, tobacco and
alcohol use, family history of cancer and passive smoke expo-
sures. Dietary information was collected using a food fre-
quency questionnaire based on the Brief Block FFQ devel-
oped by the National Cancer Institute.24
Definition of anthropometric variables
BMI (kg/m2) at 1 year before interview and BMI at age 21
were calculated from self-reported height and weight mea-
sures collected during the in-person interview. We based cut-
off points for BMI at 1 year before interview according to
categories defined by the World Health Organization. There
was a lower prevalence of individuals with BMIs greater than
25 kg/m2 in the United States before 1990s, when most study
participants would have been 21 years of age.25,26 Therefore,
to avoid sparse data issues in higher BMI categories for the
BMI at age 21 variable, we used cut-off points based on quar-
tiles of the control population for the main analyses (<20.34,
20.34 to <22.15, 22.15 to <24.34, 24.34 kg/m2) and on ter-
tiles for the stratified analyses (<20.96, 20.96 to <23.56,
23.56 kg/m2). Proportional change in BMI was defined as
[(BMI at 1 year before interview  BMI at age 21)/BMI at
age 21]100. The median time between BMI measurements
was 32 years for lung cancer cases, 30 years for SCC UADT
cancer cases and 30 years for controls. In the main analyses,
we used fine categories of BMI change that include a <5%
BMI change (loss), 5%  BMI change <5% (stable), 5 to
<15% (gain), 15 to <25% (gain), 25 to <35% (gain) and
35% (gain). Given the observed similarity of associations
across the moderate and high categories of BMI change, in
our stratified analyses, we collapsed strata to these following
categories: <5% BMI change (loss), 5%  BMI change
<5% (stable), 5 to <25% (gain) and 25% (gain).
Definition of tobacco smoking characteristics
Ever smokers were defined as having smoked at least 100 cig-
arettes in their lifetime. Former and current smokers were
defined according to smoking pack-years as light (<20),
moderate (20 to <40) or heavy (40þ) smokers.27,28 Smoking
pack-years were derived from participants’ self-reported
tobacco use over the lifespan. Cessation was defined as sus-
tained/long term (>3 years of quit time) or recent (3 years
of quit time).29 The duration of cessation (quit time) was
quantified by subtracting participants’ self-reported age at
cessation from self-reported age at interview.
Statistical analyses
The primary analyses included all lung cancer cases (n ¼
611) and all squamous cell UADT cancer cases (n ¼ 527).
The subsite and histologic analyses included lung cancer
(small cell, adenocarcinoma, large cell and squamous cell)
and SCC UADT cancer sites (oral and pharyngeal, laryngeal
and esophageal), as well as adenocarcinoma of the esophagus
(n ¼ 74). Controls more than 3 years younger than the
youngest lung cancer case or more than 3 years older than
the oldest lung cancer case (n ¼ 11) were excluded from all
analyses, and the remaining 1,029 controls were a common
control group for lung and UADT cancer cases. Crude and
adjusted odds ratios (ORs) and their 95% confidence intervals
(CIs) were estimated using unconditional logistic regression
models with stable BMI (no more than a 5% loss or gain
over time) as the reference group. For all tests of trend, the
three BMI variables (BMI at 21, BMI at 1 year before inter-
view/diagnosis and BMI change) were treated as ordinal vari-
ables and for the test of trend with BMI change, we excluded
the negative BMI change (weight loss) category. In addition
to primary and stratified analyses, we also included a product
term (BMI gain  pack-years) in our logistic model to check
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under the null hypothesis (Ho: no change in the relation of
BMI gain to cancer, across strata of pack-years). The antilog of
the coefficient estimated for the product term was interpreted
as the ratio of ORs (ROR) with a ROR = 1 indicating a depar-
ture from multiplicativity and the null hypothesis. The RORs
and their 95% CIs were estimated using unconditional logistic
regression.
As cases and controls were matched using 10-year catego-
ries, we adjusted age using fine categories (<34, 35–36, 37–
38, 39–40, 41–42, 43–44, 45–46, 47–48, 49–50, 51–52, 53–54,
55–56, 57–58 and 59–62). We also included gender, ethnicity
(White, Asian-American, African-American and Hispanic),
education (years, continuous), tobacco smoking status (never,
former, current), tobacco smoking frequency (pack-years,
continuous) and daily caloric intake (kcal, continuous) as
covariates. For UADT cancers, we adjusted for alcohol drink-
ing status (never, former, current) and frequency of alcohol
drinking (years of drinking multiplied by number of drinks
per day, continuous) in addition to the aforementioned varia-
bles. Fruit and vegetable intake and caloric intake were com-
puted using methods previously described.30 In brief, to calcu-
late fruit and vegetable consumption, we multiplied the portion
size (in grams) and number of servings per day of a given fruit
or vegetable. Quartiles of total fruit and vegetable intake were
based on the distribution of total fruit and vegetable intake in
the control population. Total daily energy intake (calories) less
than 500 or >4,500 were considered extreme values and were
replaced with the mean total energy intake of the control popu-
lation. Missing total energy intakes were imputed with the
mean total energy intake of the control population. Our find-
ings were consistent when we used either multiple imputation
(with SAS PROC IMPUTATION) or the method of excluding
all subjects with missing calorie intakes. All statistical analyses
were performed using SAS v.9.1 (SAS Institute, Cary, NC).
Results
Demographic characteristics are presented in Table 1. Lung
cancer cases differed from controls in BMI at age 21 (p ¼
0.005), but there was little difference between SCC UADT
cancer cases and controls (p ¼ 0.13). Lung (p < 0.001) and
SCC UADT (p ¼ 0.008) cancer cases differed from controls
in BMI at 1 year before interview. Lung and SCC UADT
cancer cases were more likely than controls to be smokers
(p < 0.001) or drinkers (p < 0.001). Fruit and vegetable con-
sumption differed between lung (p < 0.001) and UADT (p ¼
0.03) cancer cases and controls.
The associations between BMI and BMI change and lung
and SCC UADT cancers are presented in Table 2. BMI at
age 21 was not associated with either lung or SCC UADT
cancers, adjusting for potential confounders. BMI at 1 year
before interview was inversely related to lung (ptrend ¼ 0.001)
and SCC UADT (ptrend ¼ 0.013) cancers. BMI gain was
inversely related to lung (ptrend ¼ 0.001) and SCC UADT
cancers (ptrend ¼ 0.002), with a 25% gain associated with
lung (OR 0.53, 95% CI 0.33–0.84) and SCC UADT (OR 0.44,
95% CI 0.27–0.71) cancers. These inverse associations per-
sisted across fine (10% width) strata of BMI gain for both
lung (ptrend ¼ 0.001) and SCC UADT (ptrend ¼ 0.002) can-
cers. An inverse association with BMI gain was also observed
for different lung-cancer histologies (data not shown) and
different UADT cancer subsites (data not shown).
The results of stratified analyses are presented in Tables 3
and 4 for the relations between BMI change and lung and
SCC UADT cancers by categories of BMI at age 21, tobacco
smoking and alcohol drinking. Little variation was observed
in the relation of BMI change to lung and SCC UADT can-
cers, across strata of BMI at age 21. In current smokers, a
25% gain in BMI was inversely associated with lung (OR
0.28, 95% CI 0.13–0.57) and SCC UADT (OR 0.23, 95% CI
0.09–0.58) cancers. In former smokers, a 25% gain in BMI
was inversely associated with lung (OR 0.54, 95% CI 0.33–
0.90) and SCC UADT (OR 0.41, 95% CI 0.23–0.76) cancers.
The inverse associations persisted in moderate and heavy
smokers (20 pack-years) for both lung and SCC UADT
cancers (ptrend < 0.001). A 25% gain in BMI was associated
with lung cancer in current (OR 0.48, 95% CI 0.26–0.88) and
former (OR 0.43, 95% CI 0.21–0.89) drinkers and with
UADT cancer in current drinkers (OR 0.26, 95% CI 0.14–
0.49). However, such an inverse association was not observed
among never smokers or never drinkers.
The analysis of joint associations between BMI gain and
pack-years among subjects with a BMI gain (Table 5) yields
results consistent with those of the stratified analyses (Tables 3
and 4). Among all study participants with BMI gain, those
light and moderate smokers with a <25% BMI gain have
almost six times the odds of lung cancer (95% CI 2.98, 10.5)
and three times the odds of UADT cancers (95% CI 1.56,
5.86), compared to nonsmokers with a 25% gain in BMI in
adulthood. Heavy smokers with a <25% BMI gain have almost
85 times the odds of lung cancer (95% CI 41.8, 173) and 12
times the odds of SCC UADT cancer (95% CI 5.70, 26.1), com-
pared to nonsmokers with a 25% gain in BMI in adulthood.
These findings, in addition to estimated RORs of 1.66 for lung
cancer (p ¼ 0.059) and 1.47 for SCC UADT cancer (p ¼
0.204), suggest that smoking pack-years may modify the OR for
the effect of BMI gain on both lung and UADT cancers.
Discussion
The main finding of our analyses is that proportional gain in
BMI in adulthood was inversely associated with lung cancer
and SCC UADT cancers in middle-aged adults in Los
Angeles County. Monotonic dose–response associations were
observed for both cancer outcomes with adult BMI gain.
Two prospective cohort studies of lung cancer and two case–
control studies of UADT cancers reported similar observa-
tions.11,19–21 A cohort study of lung cancer reported that
BMI loss is strongly associated with increased risk of lung
cancer, which also supports our finding.31
When stratifying by smoking status, we found that the
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Table 1. Study population characteristics
Variable
Lung cancer cases SCC UADT cancer cases Controls
n ¼ 611 n ¼ 527 n ¼ 1,040
Ethnicity % % %
White 359 (58.8) 289 (54.8) 634 (61.0)
Hispanic 53 (8.7) 62 (11.8) 150 (14.4)
Black 96 (15.7) 68 (12.9) 102 (9.8)
Asian 70 (11.5) 59 (11.2) 62 (6.0)
Other 32 (5.2) 47 (8.9) 91 (8.8)
Missing 1 (0.16) 2 (0.4) 1 (0.1)
p-Value* <0.001 <0.001
Sex
Male 303 (49.6) 391 (74.2) 623 (59.9)
Female 308 (50.4) 136 (25.8) 417 (40.1)
Missing (0) 0 (0) 0 (0)
p-Value* <0.001 <0.001
Age, mean 6 SD 52.2 6 5.4 50.3 6 7.6 49.9 6 7.3
missing 0 (0) 0 (0) 0 (0)
p-Value** <0.001 0.32




BMI 1 year before interview,
mean 6 SD, kg/m2
26.3 6 5.7 26.7 6 5.8 27.5 6 5.7
Missing 2 (0.3) 2 (0.4) 2 (0.2)
p-Value** <0.001 0.008
BMI at age 21,
mean 6 SD, kg/m2
22.1 6 3.4 22.9 6 3.7 22.6 6 3.7
Missing 13 (2.1) 14 (2.6) 8 (0.8)
p-Value** 0.005 0.13
Years between BMI time
points, median (range)
32 (10–37) 30 (1–37) 30 (7–40)
p-Value** <0.001 0.724
Histology or subsite
Large cell 115 (18.8)
Small cell 75 (12.3)
Squamous cell 95 (15.6)
Adenocarcinoma 297 (48.6)
Missing 29 (4.7)




0–12 265 (43.4) 240 (45.5) 300 (28.9)
12–16 275 (45.0) 230 (43.6) 481 (46.3)
>16 71 (11.6) 57 (10.8) 258 (24.8)
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current smokers. Similar effect modification by smoking was
previously reported in two pooled case–control analyses of
head and neck cancers11,32 in a prospective cohort study of
lung cancer in women21 and in a prospective cohort study of
esophageal cancer.9 Because of the relatively small sample
size of nonsmokers, we did not have sufficient power to
detect similar association. Residual confounding by tobacco
smoking may distort the observed associations because smok-
ing is the strongest risk factor for both lung and UADT can-
cers. Tobacco smoking may contribute to a reduction in
body weight through appetite suppression as shown in ani-
mal studies.33 However, no correlation was observed between
pack-years of smoking and adulthood BMI change among
controls in our study (all controls: r ¼ 0.007, p-value ¼
0.807; ever-smoking controls: r ¼ 0.010, p-value ¼ 0.810),
among current smoking controls (r ¼ 0.042, p-value ¼
0.566) or former smoking controls (r ¼ 0.075, p-value ¼
0.157). Additionally, if tobacco smoking confounds the asso-
ciations between adulthood BMI change and lung and UADT
cancers, we should have observed positive associations
between BMI loss and lung and UADT cancers among smok-
ers. However, no apparent associations were observed with
BMI loss in our study among all participants, current smok-
ers or moderate and heavy smokers. Another possibility is
that the observed association may reflect the association
among tobacco quitters, who have reduced their risk of can-
cer through cessation34–37 and who might also have increased
their body weight.38–41 Therefore, one might expect an
inverse relationship among former smokers that should be
stronger than the association observed among current smok-
ers. However, we observed stronger inverse associations
among current smokers in comparison to former smokers,
Table 1. Study population characteristics (Continued)
Variable
Lung cancer cases SCC UADT cancer cases Controls
n ¼ 611 n ¼ 527 n ¼ 1,040
Tobacco smoking status % % %
Never 110 (18.0) 164 (31.1) 492 (47.3)
Former 360 (58.9) 272 (51.6) 362 (34.8)
Current 141 (23.1) 91 (17.3) 186 (17.9)
Missing 0 (0) 0 (0) 0 (0)
p-Value* <0.001 <0.001
Alcohol drinking status
Never 170 (27.8) 104 (19.7) 264 (25.4)
Former 250 (40.9) 272 (51.6) 199 (19.1)
Current 190 (31.1) 149 (28.3) 573 (55.1)
Missing 1 (0.16) 2 (0.4) 4 (0.4)
p-Value* <0.001 <0.001
Calories 1,526.2 6 700.0 1,797.1 6 1,040.9 1,478.7 6 628.4
Missing 44 (7.2) 123 (23.3) 191 (18.3)
Calories (Number of
extreme values excluded)2
1,529 6 667.1 (9) 1,750.5 6 864.5 (14) 1,483.8 6 602 (12)
p-Value** 0.190 <0.001
Fruit and vegetable intake3
Quartile 1 209 (34.2) 170 (32.3) 260 (25.0)
Quartile 2 145 (23.7) 119 (22.6) 259 (24.9)
Quartile 3 133 (21.8) 114 (21.6) 257 (24.7)
Quartile 4 115 (18.8) 117 (22.2) 258 (24.8)
Missing 9 (1.5) 7 (1.3) 6 (0.6)
p-Value* <0.001 0.030
1Controls >3 years younger than the youngest case or >3 years older than the oldest case were considered extreme. 2Self-reported daily calorie
intakes <500 and >4,500 were considered extreme. 3Quartile 1 <2.33 servings, Quartile 2 from 2.33 to 3.67, Quartile 3 from 3.67 to 5.50 and
Quartile 4 >5.50. *p-Value calculated between cases and controls using a chi-square test. **p-Value calculated between mean values of cases and
controls using a t-test.
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and there was no detectable heterogeneity across strata of
quit time for BMI gain and lung (pheterogeneity ¼ 0.931) and
UADT (pheterogeneity ¼ 0.637) cancers. Our findings suggest
that the potential for residual confounding by tobacco smok-
ing in the observed associations between adult BMI changes
and lung and UADT cancers might be minimal.
Experimental studies have suggested that tobacco smoking
may act as a modifier of the BMI change and cancer associa-
tion by influencing anabolism and metabolism. Anabolism
and metabolism are complex pathways necessary for proper
utilization of nutrients and that help determine body size and
ability to increase body mass over time. Smokers who are
able to gain weight during adulthood might represent a sub-
population with anabolic or metabolic advantages. One
mechanism that might confer biological advantage in smok-
ers is neurologic resistance to the anorexigenic effect of nico-
tine. Exposure to nicotine is expected to activate the melano-
cortin axis in the brain, thereby suppressing the appetite and
reducing food intake; however, mice that are genetically
immune to activation of this neural pathway did not experi-
ence appetite suppression or change in food intake after ex-
posure to nicotine, in comparison to normal mice.33 Tobacco
smoking may also be related to sex steroids. Some lung
tumors have been shown to express estrogen receptors,42
which suggest that estrogen may be associated with lung can-
cer. However, there remains no in-depth study to support
this hypothesis. As the conversion of androgens to estrogens
is most frequently observed in overweight and obese individ-
uals, it may be one of the mechanisms linking obesity with
the development of cancer.43 Cigarette smoke exposure is a
risk factor for lung cancer but, as it is also an inhibitor of
estrogen bioavailability,44,45 smoke exposure might modify
the risk of lung cancer in those with large BMI gains. This
effect modification might also occur with UADT cancers that
express estrogen receptors. However, there is no direct evi-
dence to support this hypothesis.
Information bias might be present in our study because
our study relied on self-report of anthropometric measures,
smoking behaviors and alcohol drinking behaviors. There is a
possibility that these measures may be subject to recall bias
because of the case–control study design. However, as body
weight and height are not recognized as risk factors for lung
or UADT cancers, recall bias of anthropometric measures is
expected to be nondifferential between cases and controls.
Table 2. BMI change and lung and SCC UADT cancers
Variables










BMI at age 21 (kg/m2)
<20.34 187/255 1.00 1.00 111/255 1.00 1.00
20.34 to <22.15 148/259 0.77 (0.59, 1.02) 0.97 (0.69, 1.35) 108/259 0.95 (0.69, 1.31) 0.93 (0.64, 1.34)
22.15 to <24.34 129/262 0.67 (0.50, 0.89) 0.89 (0.63, 1.27) 153/262 1.34 (0.99, 1.80) 1.19 (0.83, 1.72)
24.34 134/248 0.73 (0.55, 0.97) 0.93 (0.64, 1.34) 141/248 1.30 (0.96, 1.77) 1.25 (0.86, 1.81)
ptrend 0.015 0.611 0.019 0.110
BMI 1 year before interview (kg/m2)
<18.5 18/13 1.89 (0.91, 3.93) 1.31 (0.55, 3.14) 13/13 1.76 (0.80, 3.87) 2.37 (0.95, 5.92)
18.5 to <25 263/360 1.00 1.00 204/360 1.00 1.00
25 to <30 214/397 0.73 (0.58, 0.92) 0.87 (0.66, 1.16) 199/397 0.88 (0.69, 1.12) 0.90 (0.68, 1.20)
30 114/257 0.60 (0.46, 0.79) 0.58 (0.41, 0.81) 109/257 0.74 (0.56, 0.99) 0.70 (0.50, 0.98)
ptrend <0.001 0.001 0.014 0.013
BMI change
<5% (weight loss) 51/39 1.60 (0.99, 2.61) 1.09 (0.60, 1.98) 51/39 1.69 (1.04, 2.76) 1.32 (0.75, 2.31)
5 to <þ5% 113/139 1.00 1.00 107/139 1.00 1.00
5 to <15% 132/256 0.63 (0.45, 0.87) 0.76 (0.51, 1.13) 114/256 0.57 (0.41, 0.80) 0.61 (0.41, 0.90)
15 to <25% 113/214 0.65 (0.46, 0.91) 0.72 (0.47, 1.09) 105/214 0.63 (0.45, 0.89) 0.69 (0.46, 1.04
25 to <35% 67/153 0.53 (0.36, 0.78) 0.53 (0.33, 0.84) 51/153 0.43 (0.28, 0.64) 0.44 (0.27, 0.71)
35% 122/222 0.67 (0.48, 0.94) 0.53 (0.35, 0.80) 85/222 0.49 (0.34, 0.70) 0.51 (0.34, 0.78)
ptrend* 0.040 0.001 <0.001 0.002
1Adjusted for age, gender, ethnicity, tobacco smoking status, pack-years, education and calories. 2Adjusted for age, gender, ethnicity, education,
tobacco smoking status, pack-years, drinking status, drinking years and calories. *Negative BMI change (weight loss) excluded.








1412 BMI change and lung and UADT cancers
Int. J. Cancer: 131, 1407–1416 (2012) VC 2011 UICC
Table 3. Association between BMI change and lung cancer, stratified by risk factors
<5% (weight loss) 5 to <þ5% 5 to <25% 25% ptrend*
BMI at age 211 (kg/m2)
Tertile 1
Case/controls 5/1 39/36 90/137 102/169
Adj OR (95% CI)2 2.22 (0.21, 22.88) 1.00 0.63 (0.33, 1.22) 0.41 (0.21, 0.80) 0.005
Tertile 2
Case/controls 21/8 32/51 81/174 53/113
Adj OR (95% CI)2 2.64 (0.89, 7.78) 1.00 0.87 (0.46, 1.64) 0.63 (0.32, 1.25) 0.161
Tertile 3
Case/controls 25/30 42/52 74/159 34/93
Adj OR (95% CI)2 0.60 (0.24, 1.45) 1.00 0.64 (0.33, 1.23) 0.47 (0.22, 1.00) 0.042
Tobacco smoking status
Never
Case/controls 4/12 10/70 54/224 37/176
Adj OR (95% CI)3 1.59 (0.36, 7.02) 1.00 1.45 (0.66, 3.19) 1.11 (0.49, 2.54) 0.787
Former
Case/controls 30/15 63/42 142/168 120/132
Adj OR (95% CI)3 1.60 (0.72, 3.54) 1.00 0.67 (0.41, 1.08) 0.54 (0.33, 0.90) 0.017
Current
Case/controls 17/12 40/27 49/78 32/67
Adj OR (95% CI)3 0.81 (0.31, 2.10) 1.00 0.40 (0.21, 0.78) 0.28 (0.13, 0.57) 0.001
Alcohol drinking status
Never
Case/controls 11/14 25/33 66/100 61/109
Adj OR (95% CI)4 0.77 (0.24, 2.47) 1.00 1.12 (0.53, 2.38) 0.68 (0.31, 1.49) 0.173
Former
Case/controls 21/10 51/26 104/83 70/78
Adj OR (95% CI)4 0.76 (0.25, 2.24) 1.00 0.69 (0.35, 1.36) 0.43 (0.21, 0.89) 0.017
Current
Case/controls 19/15 37/79 74/286 58/187
Adj OR (95% CI)4 1.63 (0.62, 4.29) 1.00 0.62 (0.35, 1.09) 0.48 (0.26, 0.88) 0.021
Tobacco smoking pack-years
<20
Case/controls 10/15 10/48 44/163 33/120
Adj OR (95% CI)3 2.07 (0.65, 6.63) 1.00 1.24 (0.54, 2.84) 0.78 (0.32, 1.90) 0.328
20
Case/controls 37/12 93/21 147/83 119/79
Adj OR (95% CI)3 0.74 (0.31, 1.73) 1.00 0.37 (0.21, 0.67) 0.25 (0.13, 0.45) <0.001
Time since quitting tobacco smoking
3 years
Case/controls 23/7 50/8 93/24 71/17
Adj OR (95% CI)3 0.53 (0.13, 2.16) 1.00 1.16 (0.41, 3.27) 0.65 (0.22, 1.91) 0.300
>3 years
case/controls 7/8 13/34 49/144 49/115
Adj OR (95% CI)3 1.34 (0.35, 5.10) 1.00 0.89 (0.40, 1.96) 0.78 (0.35, 1.75) 0.478
1Tertile 1 <20.96, Tertile 2 from 20.96 to <23.56 and Tertile 3 23.56. 2Adjusted for age, gender, ethnicity, tobacco smoking status, pack-years,
education and calories. 3Adjusted for age, gender, ethnicity, education and calories. 4Adjusted for age, gender, ethnicity, tobacco smoking status,
pack-years, education and calories. *Negative BMI change (weight loss) excluded.
Abbreviations: Adj: adjusted; BMI: body mass index; SCC: squamous cell carcinoma.
Table 4. Association between BMI change and SCC UADT cancer, stratified by risk factors
<5% (weight loss) 5 to <þ5% 5 to <25% 25% ptrend**
BMI at 21 (kg/m2)
Tertile 1 (<20.9)
Case/controls 8/1 29/36 59/137 64/169
Adj OR (95% CI)1 9.36 (0.92, 95.0) 1.00 0.71 (0.34, 1.48) 0.52 (0.24, 1.11) 0.084
Tertile 2 (20.96 to <23.56)
Case/controls 12/8 37/51 72/174 42/113
Adj OR (95% CI)1 1.50 (0.46, 4.91) 1.00 0.48 (0.26, 0.88) 0.42 (0.22, 0.81) 0.017
Tertile 3 (23.56)
Case/controls 31/30 41/52 88/159 30/93
Adj OR (95% CI)1 0.96 (0.44, 2.07) 1.00 0.72 (0.41, 1.26) 0.44 (0.22, 0.87) 0.014
Tobacco smoking status
Never
Case/controls 14/12 26/70 78/224 40/176
Adj OR (95% CI)2 2.37 (0.88, 6.39) 1.00 0.99 (0.57, 1.74) 0.69 (0.37, 1.27) 0.146
Former
Case/controls 30/15 51/42 107/168 77/132
Adj OR (95% CI)2 1.59 (0.67, 3.80) 1.00 0.53 (0.30, 0.93) 0.41 (0.23, 0.76) 0.006
Current
Case/controls 7/12 30/27 34/78 19/67
Adj OR (95% CI)2 0.39 (0.11, 1.38) 1.00 0.39 (0.17, 0.85) 0.23 (0.09, 0.58) 0.004
Alcohol drinking status
Never
Case/controls 6/14 18/33 43/100 32/109
Adj OR (95% CI)3 0.51 (0.14, 1.85) 1.00 0.67 (0.32, 1.41) 0.59 (0.27, 1.28) 0.187
Former drinker
Case/controls 28/10 50/26 113/83 75/78
Adj OR (95% CI)3 1.35 (0.53, 3.42) 1.00 0.86 (0.47, 1.58) 0.62 (0.33, 1.17) 0.136
Current
Case/controls 16/15 39/79 63/286 28/187
Adj OR (95% CI)3 1.98 (0.83, 4.72) 1.00 0.44 (0.26, 0.74) 0.26 (0.14, 0.49) <0.001
Tobacco smoking pack-years
<20
Case/controls 12/15 19/48 51/163 39/120
Adj OR (95% CI)2 1.52 (0.52, 4.42) 1.00 0.62 (0.31, 1.23) 0.53 (0.25, 1.12) 0.157
20
Case/controls 25/12 62/21 90/83 57/79
Adj OR (95% CI)2 0.57 (0.22, 1.48) 1.00 0.36 (0.18, 0.71) 0.22 (0.10, 0.45) <0.001
Time since quitting tobacco smoking
3 years
Case/controls 24/7 40/8 63/24 39/17
Adj OR (95% CI)2 0.66 (0.18, 2.47) 1.00 0.56 (0.19, 1.59) 0.39 (0.12, 1.23) 0.133
>3 years
Case/controls 6/8 11/34 44/144 38/115
Adj OR (95% CI)2 2.60 (0.56, 12.0) 1.00 0.86 (0.36, 2.03) 0.74 (0.30, 1.79) 0.394
1Adjusted for age, gender, ethnicity, tobacco smoking status, pack-years, drinking status, drinking years, education and calories. 2Adjusted for age,
gender, ethnicity, drinking status, drinking years, education and calories. 3Adjusted for age, gender, ethnicity, tobacco smoking status, pack-years,
education and calories.
**Negative BMI change (weight loss) excluded.
Abbreviations: Adj: adjusted; BMI: body mass index; SCC: squamous cell carcinoma.
Measures of body fat distribution, such as waist circumfer-
ence or waist to hip ratio, were not measured in our study,
and we could not evaluate the independent associations
between distribution of body fat and both cancers. In addi-
tion, body fat distribution might confound our observed
associations between BMI change and lung or UADT can-
cers. However, in two prospective cohort studies by Kabat
et al.21 and Olson et al.,12 the inverse associations observed
for BMI and lung cancer persisted after adjusting for waist
circumference and lung cancer.12,21
With regard to smoking and alcohol drinking history,
recall bias may exist. However, the associations between
smoking, alcohol and lung and UADT cancers observed in
our study are consistent with published associations from
prospective cohort studies. Therefore, it is unlikely that recall
bias distorted the associations. Potential selection bias might
be present in our study, given the case–control study design.
For lung and UADT cancer cases, 30 and 14%, respectively,
did not participate because they were deceased or ill.23 Con-
sequently, cases with advanced cancers might not be repre-
sented in the case groups. However, as our study confirmed
the established associations between smoking and lung and
UADT cancers and between alcohol drinking and UADT
cancer, the possibility of selection bias of the observed associ-
ations may be largely reduced. Lastly, reverse causality might
be of concern if a positive association was noted between
BMI loss and lung and UADT cancers, given the possibility
for subclinical weight loss before cancer diagnosis. However,
there is no clear association in our study for adult weight
loss and increased risk of lung or UADT cancers.
This is the first study in the United States, in both men
and women, to examine the potential association between
BMI change and both lung and UADT cancers. In our study,
we found that a gain in adulthood BMI is inversely associ-
ated with the risk of lung and UADT cancers in both men
and women. However, given that the inverse association
between BMI gain and lung and UADT cancers persists in
smokers, future studies should focus on understanding the
potential interaction between BMI gain and smoking. It
would be advantageous to explore the potential biological
pathways in relation to BMI change to understand the under-
lying mechanisms for the relationship between adulthood
BMI gain and lung and UADT cancers.
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